venture – Talk Bio

Ouro Medicines, Immune Reset Therapeutics, Chronic Immune-Mediated Diseases, T Cell Engagers, B Cell Mediated Diseases, GSK, Monograph Capital, TPG Life Sciences Innovations, NEA, Norwest Venture Partners

Tenvie Therapeutics Launches with $200 Million to Revolutionize Neurological Disease Treatment

4 months ago talkbio0Tagged Arch of foot, Denali, F-Prime Capital, Mubadala, Neurological diseases, Partner in relationship, small molecule therapies, Tenvie, venture

Tenvie Therapeutics, neurological diseases, small molecule therapies, Denali Therapeutics, ARCH Venture Partners, F-Prime Capital, Mubadala Capital

Orbis Kicks Off 2025 with €90M Series A Funding in Fierce Biotech Fundraising Tracker

4 months ago talkbio0Tagged biotech, Biotech Fundraising Tracker, Biotech Investments, Capital, Fierce, Funding, funding rounds, Orbis, Series, venture

Fierce Biotech Fundraising Tracker 2025, Orbis Series A Funding, Biotech Venture Capital, 2025 Biotech Investments, Series A Funding Rounds

2024 Biotech IPOs: Insights and Trends

4 months ago talkbio0Tagged 2024, biopharma sector, biotech, Capital, Health care facility, innovation, Investments, IPO, IPOs, public entity, trends qualifier, venture

Biotech IPOs, 2024 IPO trends, biopharma sector, initial public offerings, venture capital investment, healthcare innovation.

Biotech Funding Boom: Tasca and Citryll Secure Significant Investments

4 months ago talkbio0Tagged Biotech Fundraising, Citryll, Fierce, Tasca, tracker, venture

Biotech fundraising, venture capital, Tasca, Citryll, Fierce Biotech Fundraising Tracker ’24

Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology

4 months ago talkbio0Tagged Aortic Valve Insufficiency, biotech, Capital, Dimensions, innovation, Machine Learning, Science, Technology, venture

Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation

Forbion Secures Over €2 Billion in Largest Fundraising to Date, Supporting 30 Biotechs

6 months ago talkbio0Tagged biotechs, Forbion, Fund III, Growth, venture, Ventures Fund VII

Forbion, venture capital, life sciences, fundraising, biotechs, Forbion Growth Opportunities Fund III, Forbion Ventures Fund VII